|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.72 USD | -1.96% |
|
+4.76% | +24.68% |
| Capitalization | 11.72B 10.08B 9.22B 8.8B 16.13B 1,124B 16.39B 111B 42.8B 534B 43.98B 43.03B 1,859B | P/E ratio 2026 * |
-118x | P/E ratio 2027 * | 39.7x |
|---|---|---|---|---|---|
| Enterprise value | 11.61B 9.99B 9.13B 8.71B 15.97B 1,114B 16.24B 110B 42.4B 529B 43.56B 42.63B 1,842B | EV / Sales 2026 * |
11.8x | EV / Sales 2027 * | 7.11x |
| Free-Float |
84.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Axsome Therapeutics, Inc.
| 1 day | -1.96% | ||
| 1 week | +4.76% | ||
| Current month | +9.61% | ||
| 1 month | +20.49% | ||
| 3 months | +24.23% | ||
| 6 months | +56.44% | ||
| Current year | +24.68% |
| 1 week | 214.31 |  | 235.92 |
| 1 month | 180 | | 235.92 |
| Current year | 152.28 | | 235.92 |
| 1 year | 96.09 | | 235.92 |
| 3 years | 55.02 | | 235.92 |
| 5 years | 19.38 | | 235.92 |
| 10 years | 1.94 | | 235.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 11/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 15/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 31/03/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 11/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 30/11/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 30/11/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.96% | +4.76% | +111.77% | +190.13% | 11.72B | |
| -2.05% | -2.33% | +17.49% | -6.85% | 71.04B | |
| -1.37% | +1.24% | +49.48% | +177.39% | 52.43B | |
| -2.07% | +41.90% | +41.90% | +41.90% | 43.84B | |
| -0.01% | -2.78% | -59.49% | -67.65% | 33.99B | |
| +0.83% | -0.26% | +53.63% | -37.00% | 28.49B | |
| -1.98% | -9.77% | +97.26% | -60.95% | 19.46B | |
| -2.38% | -3.30% | +50.54% | +47.65% | 19.04B | |
| -5.42% | -8.89% | +60.78% | +107.86% | 18.17B | |
| +0.55% | +1.33% | +43.37% | +90.58% | 16.16B | |
| Average | -1.59% | -3.82% | +46.67% | +48.31% | 31.43B | |
| Weighted average by Cap. | -1.53% | -3.76% | +35.47% | +40.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 985M 848M 775M 740M 1.36B 94.55B 1.38B 9.3B 3.6B 44.88B 3.7B 3.62B 156B | 1.59B 1.37B 1.25B 1.2B 2.19B 153B 2.23B 15.04B 5.82B 72.58B 5.98B 5.85B 253B |
| Net income | -99.84M -85.91M -78.55M -74.95M -137M -9.58B -140M -942M -365M -4.55B -375M -367M -15.84B | 316M 272M 249M 237M 435M 30.31B 442M 2.98B 1.15B 14.39B 1.19B 1.16B 50.12B |
| Net Debt | -111M -95.25M -87.09M -83.1M -152M -10.62B -155M -1.04B -404M -5.04B -415M -407M -17.56B | -394M -339M -310M -296M -542M -37.78B -551M -3.72B -1.44B -17.94B -1.48B -1.45B -62.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 227.72 $ | -1.96% | 549,548 |
| 14/05/26 | 232.27 $ | -1.30% | 572,510 |
| 13/05/26 | 235.32 $ | +5.04% | 815,619 |
| 12/05/26 | 224.03 $ | +3.49% | 633,376 |
| 11/05/26 | 216.47 $ | -0.42% | 738,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AXSM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition